The infrastructure of electrophysiology centers impacts the management of cardiac tamponade-Results from a national survey.
cardiac tamponade
catheter ablation
institutional infrastructure
survey
Journal
Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
revised:
27
06
2023
received:
25
03
2023
accepted:
13
07
2023
medline:
23
10
2023
pubmed:
1
8
2023
entrez:
1
8
2023
Statut:
ppublish
Résumé
Although electrophysiological (EP) centers have institutional standards, evidence on management of cardiac tamponade is lacking. A physician-based survey was conducted by sending out questionnaires to all hospitals in Germany performing EP procedures. To evaluate the infrastructure of EP centers and the impact of center volume and onsite cardiac surgery on the management of cardiac tamponade, the results of the survey were analyzed for low-volume (0-250 procedures per year), mid-volume (250-500 procedures), and high-volume (>500 procedures) centers, as well as for centers with and without onsite cardiac surgery. A total of 341 centers were identified and 189/341 (55%) returned data sets were analyzed. Most types of EP procedures are performed across all kinds of centers. Ablation of ventricular tachycardia (VT) is concentrated in higher volume centers and in centers with onsite cardiac surgery. None of the participating low-volume centers and only 13% of centers without onsite cardiac surgery responded to performing epicardial VT ablation. Irrespective of center volume and onsite cardiac surgery, neither body mass index nor age was reported to be an exclusion criterion for ablation procedures. Higher volume centers and centers with onsite cardiac surgery more often have dedicated EP laboratories and EP-nursing teams. Also, differences regarding periprocedural safety precautions and management of cardiac tamponade were found for low-, mid-, and high-volume centers, as well as for centers with and without onsite cardiac surgery. While center volume and onsite cardiac surgery do not impact patient selection, there are differences in ablation spectrum, infrastructure, periprocedural safety precautions, and treatment of tamponade.
Sections du résumé
BACKGROUND
BACKGROUND
Although electrophysiological (EP) centers have institutional standards, evidence on management of cardiac tamponade is lacking.
AIM AND METHODS
OBJECTIVE
A physician-based survey was conducted by sending out questionnaires to all hospitals in Germany performing EP procedures. To evaluate the infrastructure of EP centers and the impact of center volume and onsite cardiac surgery on the management of cardiac tamponade, the results of the survey were analyzed for low-volume (0-250 procedures per year), mid-volume (250-500 procedures), and high-volume (>500 procedures) centers, as well as for centers with and without onsite cardiac surgery.
RESULTS
RESULTS
A total of 341 centers were identified and 189/341 (55%) returned data sets were analyzed. Most types of EP procedures are performed across all kinds of centers. Ablation of ventricular tachycardia (VT) is concentrated in higher volume centers and in centers with onsite cardiac surgery. None of the participating low-volume centers and only 13% of centers without onsite cardiac surgery responded to performing epicardial VT ablation. Irrespective of center volume and onsite cardiac surgery, neither body mass index nor age was reported to be an exclusion criterion for ablation procedures. Higher volume centers and centers with onsite cardiac surgery more often have dedicated EP laboratories and EP-nursing teams. Also, differences regarding periprocedural safety precautions and management of cardiac tamponade were found for low-, mid-, and high-volume centers, as well as for centers with and without onsite cardiac surgery.
CONCLUSION
CONCLUSIONS
While center volume and onsite cardiac surgery do not impact patient selection, there are differences in ablation spectrum, infrastructure, periprocedural safety precautions, and treatment of tamponade.
Identifiants
pubmed: 37526378
doi: 10.1002/clc.24096
pmc: PMC10577558
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1210-1219Informations de copyright
© 2023 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.
Références
Circulation. 2008 May 20;117(20):2583-90
pubmed: 18474813
Clin Cardiol. 2023 Oct;46(10):1210-1219
pubmed: 37526378
Europace. 2018 Dec 1;20(12):1944-1951
pubmed: 29982554
Herzschrittmacherther Elektrophysiol. 2020 Dec;31(4):381-387
pubmed: 32676836
Circ Arrhythm Electrophysiol. 2010 Feb;3(1):32-8
pubmed: 19995881
J Cardiovasc Electrophysiol. 2022 Apr;33(4):654-663
pubmed: 35118743
Europace. 2020 Aug 1;22(8):1240-1251
pubmed: 32500141
Heart Rhythm. 2017 Jun;14(6):819-827
pubmed: 28232261
Clin Res Cardiol. 2023 Jun;112(6):854
pubmed: 35925393
Europace. 2018 May 1;20(5):772-777
pubmed: 29741689
Catheter Cardiovasc Interv. 2019 Jan 1;93(1):E56-E62
pubmed: 30244510
Int J Cardiol. 2019 Mar 1;278:108-113
pubmed: 30287056
Circ Arrhythm Electrophysiol. 2014 Aug;7(4):684-90
pubmed: 24958396
Chin Med J (Engl). 2010 Apr 5;123(7):961-3
pubmed: 20497695
J Am Coll Cardiol. 2000 Jun;35(7):1905-14
pubmed: 10841242
Europace. 2016 Apr;18(4):543-9
pubmed: 26826139
JACC Clin Electrophysiol. 2017 Feb;3(2):154-161
pubmed: 29759388